Search Results - "The International Journal of Neuropsychopharmacology"
-
1
Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior
Published in The international journal of neuropsychopharmacology (01-08-2016)“…There is a growing recognition of the importance of the commensal intestinal microbiota in the development and later function of the central nervous system…”
Get full text
Journal Article -
2
Making Sense of Rodent Models of Anhedonia
Published in The international journal of neuropsychopharmacology (01-11-2018)“…A markedly reduced interest or pleasure in activities previously considered pleasurable is a main symptom in mood disorder and psychosis and is often present…”
Get full text
Journal Article -
3
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Published in The international journal of neuropsychopharmacology (01-02-2019)“…The underlying neurobiological basis of major depressive disorder remains elusive due to the severity, complexity, and heterogeneity of the disorder. While the…”
Get full text
Journal Article -
4
An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
Published in The international journal of neuropsychopharmacology (01-04-2019)“…Abstract Background Although originally marketed as safe alternatives to the habit-forming benzodiazepines, growing numbers of zaleplon, zolpidem, and…”
Get full text
Journal Article -
5
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
Published in The international journal of neuropsychopharmacology (01-04-2016)“…Background: Several recent trials indicate low-dose ketamine produces rapid antidepressant effects. However, uncertainty remains in several areas: dose…”
Get full text
Journal Article -
6
Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder
Published in The international journal of neuropsychopharmacology (01-08-2019)“…People with bipolar disorder frequently experience persistent residual symptoms, problems in psychosocial functioning, cognitive impairment, and poor quality…”
Get full text
Journal Article -
7
Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials
Published in The international journal of neuropsychopharmacology (01-02-2016)“…Background: Findings of substantial remaining morbidity in treated major depressive disorder (MDD) led us to review controlled trials of treatments aimed at…”
Get full text
Journal Article -
8
Gut Microbiota and Brain Function: An Evolving Field in Neuroscience
Published in The international journal of neuropsychopharmacology (01-05-2016)“…There is a growing appreciation of the importance of gut microbiota to health and disease. This has been driven by advances in sequencing technology and recent…”
Get full text
Journal Article -
9
Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders
Published in The international journal of neuropsychopharmacology (01-04-2021)“…Abstract Background Transcranial direct current stimulation has shown promising clinical results, leading to increased demand for an evidence-based review on…”
Get full text
Journal Article -
10
Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
Published in The international journal of neuropsychopharmacology (01-02-2011)“…Accruing data suggest that oxidative stress may be a factor underlying the pathophysiology of bipolar disorder (BD), major depressive disorder (MDD), and…”
Get full text
Journal Article -
11
Interferon-Alpha Reduces Human Hippocampal Neurogenesis and Increases Apoptosis via Activation of Distinct STAT1-Dependent Mechanisms
Published in The international journal of neuropsychopharmacology (01-02-2018)“…In humans, interferon-α treatment for chronic viral hepatitis is a well-recognized clinical model for inflammation-induced depression, but the molecular…”
Get full text
Journal Article -
12
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Published in The international journal of neuropsychopharmacology (01-09-2008)“…Oxidative stress has been implicated in the pathogenesis of diverse disease states, and may be a common pathogenic mechanism underlying many major psychiatric…”
Get full text
Journal Article -
13
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm
Published in The international journal of neuropsychopharmacology (01-02-2017)“…Abstract Background: The current paper includes a systematic search of the literature, a detailed presentation of the results, and a grading of treatment…”
Get full text
Journal Article -
14
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients
Published in The international journal of neuropsychopharmacology (01-10-2016)“…Background: Increased levels of inflammation have been associated with a poorer response to antidepressants in several clinical samples, but these findings…”
Get full text
Journal Article -
15
Small Extracellular Vesicles in Rat Serum Contain Astrocyte-Derived Protein Biomarkers of Repetitive Stress
Published in The international journal of neuropsychopharmacology (01-03-2019)“…Abstract Background Stress precipitates mood disorders, characterized by a range of symptoms present in different combinations, suggesting the existence of…”
Get full text
Journal Article -
16
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Published in The international journal of neuropsychopharmacology (01-10-2019)“…About one-third of patients with depression fail to achieve remission despite treatment with multiple antidepressants and are considered to have…”
Get full text
Journal Article -
17
Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene
Published in The international journal of neuropsychopharmacology (01-01-2015)“…Epigenetic drugs like sodium butyrate (NaB) show antidepressant-like effects in preclinical studies, but the exact molecular mechanisms of the antidepressant…”
Get full text
Journal Article -
18
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
Published in The international journal of neuropsychopharmacology (01-06-2018)“…This European multicenter study aimed to elucidate suicidality in major depressive disorder. Previous surveys suggest a prevalence of suicidality in major…”
Get full text
Journal Article -
19
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
Published in The international journal of neuropsychopharmacology (01-06-2012)“…The efficacy, safety, and tolerability of Lu AA21004 vs. placebo using venlafaxine XR as active reference in patients with DSM-IV-TR major depressive disorder…”
Get full text
Journal Article -
20
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response
Published in The international journal of neuropsychopharmacology (01-08-2014)“…Variation in the serotonin transporter gene (5-HTT; SERT; SLC6A4) has been suggested to pharmacogenetically drive interindividual differences in antidepressant…”
Get full text
Journal Article